Based on its implication in focal amplifications and gains together with strong upregulation in development of TH-MYCN driven NB in mice and inverse correlation with survival in NB patients, our team further investigated the role of RRM2 through in vitro and in vivo experiments [125]. This evidence concerns the gene MYCN and neuroblastoma.